Friedreich's Ataxia Completed Phase 2 Trials for TAK-831 (DB16067)
Also known as: Friedreich Ataxia / Friedreich's ataxia (disorder)
Indication | Status | Phase |
---|---|---|
DBCOND0037758 (Friedreich's Ataxia) | Completed | 2 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT03214588 | Efficacy, Tolerability, and Pharmacokinetics of Multiple Doses of Oral TAK-831 in Adults With Friedreich Ataxia | Treatment |